Vault develops the most viable and medically-relevant assets by concentrating on your portfolio prioritization and disease area focus. We create your target product profiles and developmental plans that underscore differentiation potential, provide sufficient safety and efficacy data, and permit effective asset evaluation for “out-licensing” opportunities and support business development in-licensing activities by performing customized assessments of potential acquisition targets.

We create dynamic target product profiles for your asset and its competitors by analyzing available in-house data and assessing competitor developmental programs and product attributes. The resulting integrated product development plan focuses on streamlined safety/efficacy data gathering, executional efficiency, and achieving timely global approval with the best possible label and favorable pricing/reimbursement.

Our lifecycle management strategy discovers novel ways to demonstrate product clinical benefits, providing differentiation versus existing or future therapies. Vault’s unparalleled experience allows us to identify areas for new product enhancement not previously realized. By performing in-depth data review and data mining efforts we can uncover additional asset optimization strategies. By working closely with you, Vault supports launch-related clinical, publication and KOL activities, and promotes competitive Phase 4 clinical trial strategies.

Vault Bioventures creates, uncovers, & captures the value of your biopharmaceutical assets through marketplace adoption, investment decisions and operational execution.

By harnessing the power of integration, we align and facilitate your key organizational strategic and operational levers to deliver value driven solutions and break-through business performance.

Our team guides you through stakeholder ecosystems by analyzing complex infrastructures, evaluating organizational patterns, & providing detailed, unrealized roadmaps.